Sector: Health Care
Director information for XENON PHARMACEUTICALS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Christopher Kenney, MD, FAAN, M.B.A. | Chief Medical Officer | 55 | ["MD","FAAN","M.B.A."] | [] | 2026 |
| Darren Cline, M.B.A. | Chief Commercial Officer | 61 | ["M.B.A."] | [] | 2026 |
| Dawn Svoronos | Lead Independent Director | 72 | ["Experience in commercialization of pharmaceutical products","Senior management experience in the pharmaceutical industry"] | [] | 2026 |
| Elizabeth Garofalo | Director | 68 | ["MD from the Indiana University School of Medicine","Leadership roles in pharmaceutical industry","Expertise in drug development and therapeutic product lifecycle management","Focus on neurology and epilepsy","Risk mitigation oversight"] | ["Institute for Advanced Clinical Trials for Children (I-ACT) - Chair of the Board","Pediatric Oversight Committee","Business Advisory Board for the Epilepsy Foundation of America"] | 2026 |
| Gary Patou | Director | 67 | ["Chief Medical Officer at Star Therapeutics Inc. since August 2020","Board member and Chief Medical Officer for BioIntervene Inc. since January 2019","Executive Partner at MPM Capital from 2005 until 2020","Interim Chief Medical Officer in various MPM portfolio companies","Executive Vice President and Chief Medical Officer of Oscient Pharmaceuticals Corp.","Senior Vice President and Director, Project and Portfolio Management at SmithKline Beecham Pharmaceuticals","Academic appointments at University College & Middlesex School of Medicine","B.Sc. from University of London","M.D. from University College London"] | [] | 2026 |
| Gillian Cannon | Director | 62 | ["More than 30 years of experience in the pharmaceutical industry","Leadership roles at multiple prominent global pharmaceutical companies"] | [] | 2026 |
| Ian Mortimer | President and Chief Executive Officer and Director | 50 | ["Served as President and CEO of Xenon since June 2021","Held roles at Xenon including CFO, President, COO, and Corporate Secretary","Managed finances and capital markets at Tekmira Pharmaceuticals Corporation","Former CFO at Inex Pharmaceuticals","Board member for BIOTECanada","Earned MBA from Queen’s University and BSc in microbiology from University of British Columbia"] | [] | 2026 |
| Ian Mortimer, M.B.A., CPA, CMA | President and Chief Executive Officer and Director | 50 | ["M.B.A.","CPA","CMA"] | [] | 2026 |
| Justin Gover | Director | 55 | ["Nearly 25 years of experience in biotechnology industry","Founding CEO and director of GW Pharmaceuticals","Led commercialization of Epidiolex®","Served on the board of directors of Biotechnology Innovation Organization (BIO)","Current board member of Compass Pathways plc, CURE Epilepsy, and Rady Children’s Institute for Genomic Medicine","M.B.A. from INSEAD business school","B.Sc. (Hons) from Bristol University"] | [] | 2026 |
| Patrick Machado | Director | 62 | ["Co-founded and served as CFO and Chief Business Officer at Medivation, Inc.","Led the company through substantial growth and challenges during clinical development and launch of XTANDI®","Served on boards of various biotechnology companies","Experience with ProDuct Health, Inc. as Senior Vice President and General Counsel","Worked for Morrison & Foerster LLP and Massachusetts Supreme Judicial Court","Received J.D. from Harvard Law School and degrees in Economics and German from Santa Clara University"] | [] | 2026 |
| Steven Gannon | Director | 64 | ["financial expertise","senior management experience in the pharmaceutical industry"] | [] | 2026 |
